Today's Hours: 10:00am - 6:00pm
Lane Medical Library

Search

Filter Results

Did You Mean:

Search Results

Sort by
relevance
  • Book
    edited by Steven A. Kaplan, Kevin T. McVary.
    Contents:
    Etiology and pathogenesis / Robert H. Getzenberg and Prakash Kulkarni
    Lower urinary tract symptoms and benign prostatic hyperplasia : epidemiology, correlates, and risk factors / Raymond C. Rosen and Benjamin N. Breyer
    Clinical assessment and diagnosis of lower urinary tract dysfunction (LUTD) : United States / Christopher P. Filson and John T. Wei
    Clinical assessment and diagnosis of LUTS/BPH : Europe / Stavros Gravas and Jean J.M.C.H. de la Rosette
    Clinical assessment and diagnosis of LUTS/BPH : primary care / Matt T. Rosenberg, John Riley, and Marty M. Miner
    Watchful waiting / Reginald Bruskewitz
    Alpha-adrenergic antagonists for lower urinary symptoms secondary to benign prostatic hyperplasia / Nathaly Francois, Raunak D. Patel, Kevin T. McVary
    5-Alpha reductase inhibitors (5-ARIs) / Claudius, Füllhase, and Roberto Soler
    Anti-muscarinics / Nadir I. Osman and Christopher R. Chapple
    The use of PDE-5 inhibitors in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia / Casey Lythgoe and Kevin T. McVary
    Combination medical therapy for male LUTS / Claus G. Roehrborn
    Complementary therapy / Aaron E Katz and Anne Darves-Bornoz
    Open simple prostatectomy / Annika Herlemann, Matthias Oelke, and Christian Gratzke
    Minimally invasive therapies / Mauro Gacci, Matteo Salvi, and Arcangelo Sebastianelli
    Holmium laser therapy / Peter Gilling
    Greenlight laser therapy / Alexis E. Te and Bilal Chughtai
    Monopolar and bipolar transurethral resection of the prostate / Aaron M. Bernie and Richard Lee.
    Digital Access Wiley 2014
  • Article
    van Rooijen N.
    J Immunol Methods. 1977;15(3):267-77.
    Several methods are available for labelling lymphoid cells with radioactive markers e.g. 3H, 14C, 125I, 131I, 35S, 75Se, based on general metabolic processes, involving DNA, RNA and protein synthesis in these cells. Together with methods for labelling lymphoid cells with 51Cr and 99mTc, radioisotopes which are captured in cells but not incorporated in its metabolites, these will be reviewed in the present paper. Attention will be given to possible applications of the use of radiosotope labels.
    Digital Access Access Options